Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Delphine Planas, Nell Saunders, Piet Maes, Florence Guivel‐Benhassine, Cyril Planchais, Julian Buchrieser, William Bolland, Françoise Porrot, Isabelle Staropoli, Frédéric Lemoine, Hélène Péré, David Veyer, Julien Puech, Julien Rodary, Guy Baela, Simon Dellicour, Joren Raymenants, Sarah Gorissen, Caspar Geenen, Bert Vanmechelen, Tony Wawina-Bokalanga, Joan Martí-Carrerasi, Lize Cuypers, Aymeric Sève, Laurent Hocqueloux, Thiérry Prazuck, F.A. Rey, Etienne Simon-Lorrière, Timothée Bruel, Hugo Mouquet, Emmanuel André, Olivier Schwartz
Topics & Concepts
NeutralizationVirologyMonoclonal antibodyAntibodyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VaccinationMedicineBiologyVirusInfectious disease (medical specialty)ImmunologyDiseasePathologySARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies